<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	line-height:107%;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;
	font-weight:normal;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	line-height:107%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#1F3763;
	font-weight:normal;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Calibri Light",sans-serif;
	color:#1F3763;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
.MsoPapDefault
	{margin-bottom:8.0pt;
	line-height:107%;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=EN-AU>

<div class=WordSection1>

<h1><span lang=EN-US style='font-size:15.0pt;line-height:107%'>2018B11 Describe
the pharmacology of midazolam.</span></h1>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>List:</span></h3>

<p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>PC</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>PK</span></p>

<p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>PD</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>Physicochemical:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Presentation</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;line-height:
  normal'><span lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>5mg in 5mL ampoule, aqueous solution</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;line-height:
  normal'><span lang=EN-US>Also as tablets</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Structure</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Heterocyclic benzodiazepine</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>I<i>midazol</i>e moiety</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Tautomerism</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>In ampoule: pH 3.5, diaz ring open, water soluble (protonation of
  imidazole nitrogen)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>In blood: pH 7.4 diaz ring closed, lipid soluble, can cross
  blood-brain barrier</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Transformation at pH 4</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Ionisation</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;line-height:
  normal'><span lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>pKa 6.5, weak base. 90% unionized at pH 7.4</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>Pharmacokinetic:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Routes</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;line-height:
  normal'><span lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>IV, IM, SC, PO, IN, PR</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Dosing</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>IV induction: 0.3mg/kg</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>IV pre-induction adjuvant: 0.025mg/kg</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>PO pre-med: 0.5mg/kg</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Time course</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>(short acting)</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Onset IV 2 mins</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Peak IV 10 mins</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Duration IV 1-6 hours (prolonged if elderly, liver disease, acute
  illness)</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Absorption</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;line-height:
  normal'><span lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Oral bioav 50%</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Distribution</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Plasma protein binding 98%</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>V<sub>DSS</sub> 1.5L/kg</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Highly lipid soluble</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>t<sub>1/2ke0</sub> 4 minutes</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Metabolism</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Hepatic</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Phase 1 (3A4) then phase 2</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Cl 5-10mL/kg/min</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Active metabolites: </span><span lang=EN-US>α-</span><span
  lang=EN-US>OH-midaz (50% as active) and oxazepam (active)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:39.25pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span><span lang=EN-US>These
  undergo glucuronidation</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>t<sub>1/2</sub></span><sub><span lang=EN-US>β</span></sub><span
  lang=EN-US> 2 hours</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Excretion</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>&lt;1% midazolam -&gt; urine</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Glucuronidated metabolites -&gt; urine</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>Pharmacodynamic:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=102 valign=top style='width:76.6pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Mechanism of action</span></p>
  </td>
  <td width=549 valign=top style='width:412.05pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Positive allosteric modulator at BDZ site on GABA-A receptor, at
  A-G interface</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>↑probability of active conformation</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>↑Cl<sup>-</sup> conductance, prevention of depolarisation to
  action potential</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>(Not hyperpolarization, since RMP -70mV and Cl- Nernst potential
  -65mV)</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>GABA-A subtypes</span></p>
  </td>
  <td width=549 valign=top style='width:412.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>α</span><sub><span lang=EN-US>1</span></sub><span lang=EN-US>:
  sedation, amnesia, anticonvulsant</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>α</span><sub><span lang=EN-US>2</span></sub><span lang=EN-US>, </span><span
  lang=EN-US>α</span><sub><span lang=EN-US>3</span></sub><span lang=EN-US>:
  muscle relaxation, anxiolysis</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Drug interactions</span></p>
  </td>
  <td width=549 valign=top style='width:412.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Synergistic with propofol, volatile anaesthetics at GABA-A</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Synergistic with opioids in causing respiratory depression</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Antagonised by flumazenil (competitive antagonist)</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Specific use</span></p>
  </td>
  <td width=549 valign=top style='width:412.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Premedication for children</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Sedation for procedures or in ICU</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Adjuvant at induction</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Induction agent if high cardiovascular risk (e.g. CABG with
  fentanyl)</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>CNS effects</span></p>
  </td>
  <td width=549 valign=top style='width:412.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Dose-dependent in this order:</span></p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Anxiolysis</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Antegrade amnesia</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Sedation</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Anticonvulsant</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Muscle relaxation</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Hypnosis (here?)</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Also:</span></p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>↓MAC</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>↓CMRO<sub>2</sub></span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>↓Side effects of ketamine</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>10% risk paradoxical reaction in children; agitation, violence
  etc.</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Respiratory</span></p>
  </td>
  <td width=549 valign=top style='width:412.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>↓TV more than ↓RR; mild ↑PaCO<sub>2</sub></span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:44.0pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span><span lang=EN-US>Synergistic
  depression with opioids</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:44.0pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span><span lang=EN-US>Can be
  dangerous if sleep-disordered breathing</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>↓Airway reflexes</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Cardiovascular</span></p>
  </td>
  <td width=549 valign=top style='width:412.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;line-height:
  normal'><span lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>↓SNS output: -&gt; mild ↓cardiac output, ↓SVR,
  ↓mAP</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Special</span></p>
  </td>
  <td width=549 valign=top style='width:412.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Paradoxical reaction 1 in 10 children; agitation, rage</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Much slower offset if elderly, unwell, liver failure (? slower
  metabolite elimination)</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.65pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Risk delirium in elderly, ? risk of prolonged cognitive impairment</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

</div>

<p class="MsoNormal">Feedback welcome at <a href="mailto:ketaminenightmares@gmail.com">ketaminenightmares@gmail.com</a></p>
</body>

</html>
